In order to detect malignant mesothelioma at an early stage, a group of study researchers from the University of New South Wales has developed a breath test. They have developed an electronic nose, which will help doctors to differentiate between benign and malignant mesothelioma.
Study leader Deborah Yates, who is an Associate Professor at St Vincent's Clinical School, said that the development will help them a lot in carting out further studies. Further explaining the benefits of the device, Yates was of the view that the detection will help them to curb the disease on time.
“We tried to exclude the other asbestos diseases because it’s very important from a patient’s point of view that you don’t pick up something that is a benign”, further affirmed Yates. Getting affected with asbestos related problem is quite common in Australia and now in the world, this truth has been recognized.
It is quite difficult to diagnose malignant mesothelioma at an early stage and this is the reason that approximately 20,000 people have to lose their lives for the same, across the globe. It is expected that the recent development will help doctors to diagnose their problem on time, so that they could start timely treatment.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki